《大行報告》高盛:保誠(02378.HK)去年新業務盈利勝預期 評級「買入」看185元
高盛發表報告指,保誠(02378.HK)去年業績表現強勁,其中新業務盈利優於預期,經營利潤增長也具韌性,對其股份評級爲「買入」,目標價185元。
該行表示,集團新業務盈利勝預期主要由產品組合改善推動,並轉化成香港及新加坡的毛利大幅擴張,而印尼的毛利亦持續穩定。
報告補充,留意到本港新業務盈利按年下跌,主要反映2020年首季內地訪港旅客銷售貢獻。在新業務盈利而言,本地板塊按年升9%,受保障產品首年保費收入按年升12%推動。保誠專注於健康及保障類產品,以及高利潤儲蓄產品的策略,料支持今年度增長,即使與內地通關進展仍具不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.